WIKLER MATTHEW 4
4 · Matinas BioPharma Holdings, Inc. · Filed Nov 10, 2020
Insider Transaction Report
Form 4
WIKLER MATTHEW
Director
Transactions
- Award
Stock option (right to buy)
2020-11-02+122,605→ 122,605 totalExercise: $0.82Exp: 2030-11-02→ Common Stock (122,605 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.